There are those AAV's again. some earlier posts suggest the AAV's had problems triggering immune reaction and interest had wained, yet bigpharma seemed to suggest the issue was only with earlier AAV's and now plain sailing?? Wish i knew which was correct, do AAV' s have limitations in real life but work fine in vitro or in vivo trials?
There are those AAV's again. some earlier posts suggest the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
0.000(0.00%) |
Mkt cap ! $699.9M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.23 | $1.20 | $1.030M | 858.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1452 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 11842 | 3 |
View Market Depth
| Last trade - 14.14pm 24/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |